Shaokui Wei

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation
    Shaokui Wei
    Division of Epidemiology, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993 0002, USA
    Circ Cardiovasc Qual Outcomes 4:346-54. 2011

Detail Information

Publications1

  1. doi request reprint Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation
    Shaokui Wei
    Division of Epidemiology, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993 0002, USA
    Circ Cardiovasc Qual Outcomes 4:346-54. 2011
    ..We asked whether elevated B-type natriuretic peptide (BNP) level is associated with increased risk of in-hospital mortality or cardiac arrest in patients undergoing ICD implantation...